Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.15% · OPTIONAL
· Services-Offices & Clinics of Doctors of Medicine
RESEARCH SNAPSHOTTeladoc Health, Inc.'s latest supported as-filed period reports revenue of $606.9M, 4.0% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.15% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 10.65% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -3.95% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 4.75% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value -6.11% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 10.36% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Operating income changed +31.8% from the comparable as-filed period.
Operating margin changed +250 basis points from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
TDOC · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0002037711-26-000006SEC ↗4Sep 3, 2026Period Sep 1, 20260001375088-26-000006SEC ↗4Sep 3, 2026Period Sep 1, 20260002036989-26-000014SEC ↗4Sep 3, 2026Period Sep 1, 20260001714468-26-000012SEC ↗4Sep 3, 2026Period Sep 1, 20260001347535-26-000009SEC ↗4Sep 3, 2026Period Sep 1, 20260002037547-26-000008SEC ↗4Sep 1, 2026Period Sep 1, 20260001575709-26-000006SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 2, 2026Filed Sep 3, 2026 | Nueno CarlosPresident, International | Open Market SaleDirect | 6,200 | $6 | $39,066 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Nueno CarlosPresident, International | Option ExerciseDirect | 4,556 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Nueno CarlosPresident, International | Option ExerciseDirect | 8,717 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Nueno CarlosPresident, International | Option ExerciseDirect | 4,556 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.53% · OPTIONAL
Net income changed -19.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -58.4% from the comparable as-filed period.
SBC / revenue changed -200 basis points from the comparable as-filed period.
Revenue changed -4.0% from the comparable as-filed period.
Inventory changed -24.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001477449-26-000044| Nueno CarlosPresident, International |
| Option ExerciseDirect |
| 8,717 |
| $0 |
| $0 |
| Form 4 ↗ |
| Sep 1, 2026Filed Sep 1, 2026 | Grasher Michael FChief Financial Officer | Grant Or AwardDirect | 239,616 | $0 | $0 | Form 4 ↗ |
| Aug 3, 2026Filed Aug 4, 2026 | Anquillare Mark VDirector | Grant Or AwardDirect | 37,425 | $0 | $0 | Form 4 ↗ |